Surgalign Holdings, Inc.
NASDAQ
Recommendation
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -50.49M | -54.61M | -60.86M | -58.93M | -53.24M |
| Total Depreciation and Amortization | 2.12M | 2.18M | 2.36M | 2.51M | 1.89M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -333.00K | 5.86M | 20.98M | 28.32M | 36.97M |
| Change in Net Operating Assets | 6.71M | -5.55M | -18.44M | -9.95M | -10.40M |
| Cash from Operations | -41.99M | -52.11M | -55.97M | -38.05M | -24.78M |
| Capital Expenditure | -6.82M | -6.78M | -7.78M | -11.51M | -9.73M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -5.00M | -5.00M | -5.00M |
| Divestitures | 17.00M | -- | -- | -- | -- |
| Other Investing Activities | -429.00K | -475.00K | -503.00K | -522.00K | -419.00K |
| Cash from Investing | 9.75M | -7.26M | -13.28M | -17.03M | -15.15M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 11.08M | 28.81M | 18.32M | 18.32M | 18.14M |
| Repurchase of Common Stock | -86.00K | -71.00K | -101.00K | -119.00K | -68.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -4.08M | -4.08M | -4.08M | -4.08M |
| Cash from Financing | 11.00M | 24.66M | 14.14M | 14.12M | 13.99M |
| Foreign Exchange rate Adjustments | -1.00M | -285.00K | 598.00K | 1.05M | 1.37M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -22.25M | -34.99M | -54.52M | -39.91M | -24.58M |